ABALONE BIO, INC.
Berkeley, CA · Biotech · Private
Selective CB2 receptor agonist antibody (ABt140) for endometriosis pain treatment
abalonebio.com →- Grants
- $8.7M
- 11 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 1 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: A platform for identifying antibodies that modulate human membrane receptors involved in disease | $225,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: A platform for identifying antibodies that modulate human membrane receptors involved in disease | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain | $299,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Therapeutic antibodies for treating liver fibrosis | $349,013 | |
| Federal grant | Department of Health and Human Services · Phase I · Therapeutic Antibodies for Treating Inflammatory Bowel Disease | $300,241 | |
| Federal grant | Department of Health and Human Services · Phase II · Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain | $1,979,001 | |
| Federal grant | Department of Health and Human Services · Phase II · Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain | $1,063,128 | |
| Federal grant | Department of Health and Human Services · Phase I · Antibody agonist for a G protein-coupled receptor as a treatment for pain in endometriosis | $292,942 | |
| Federal grant | Department of Health and Human Services · Phase II · Therapeutic antibodies for treating liver fibrosis | $1,999,998 | |
| Federal grant | Department of Health and Human Services · Phase II · Therapeutic antibodies for treating liver fibrosis | $999,999 | |
| Federal grant | Department of Health and Human Services · Phase I · A peripherally restricted MOR agonist for effective pain management with reduced risks | $399,230 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1162 | NANOMEDIC INC | — | — |
| 1163 | AnkyrBio LLC | — | — |
| 1164 | YOURCHOICE THERAPEUTICS INC | — | — |
| 1165 | ABALONE BIO, INC. | — | — |
| 1166 | Arcus Biosciences | — | — |
| 1167 | LARIX BIOSCIENCE LLC | — | — |
| 1168 | Neumentum, Inc. | — | $27M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Yeast Display Of Proteins In The Periplasmic Spaceapplication
- Yeast Display Of Proteins In The Periplasmic Spacegranted
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
- Yeast Display Of Proteins In The Periplasmic Spaceapplication
- Cannabinoid Receptor Type 2 Antibodies And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.